Background
This article provides an overview of a recent market research report published by DataM Intelligence, a global market intelligence firm. Titled “Top Companies Advancing Nanotechnology in Drug Delivery Systems,” the report focuses on the pivotal players and their strategies within the nanotechnology-based drug delivery systems market, specifically examining the application of nanotechnology across the global pharmaceutical and biotechnology industries.
Key Findings
The report underscores that global pharmaceutical and biotechnology leaders such as Pfizer, Moderna, and AstraZeneca are committing substantial strategic investments in nanotechnology, particularly in lipid nanoparticle (LNP) technology. LNP technology has emerged as a dominant force in nucleic acid-based therapeutics, with its successful deployment in COVID-19 vaccines serving as a springboard for rapidly expanding applications into oncology, rare genetic disorders, and chronic diseases. These companies are intensely focused on leveraging nanotechnology to enhance targeted delivery efficiency and optimize drug absorption, thereby leading the competitive race to develop next-generation therapeutics.
Source: https://www.datamintelligence.com/blogs/top-companies-nanotechnology-drug-delivery-systems
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime
Comments